Ablative Solutions

Organisation

Trials

  • NCT07083765

    Phase 3, Not yet recruiting, 202 people, 24 Jul 2025

  • NCT02910414

    Phase 3, Active, not recruiting, 300 people, 22 Sept 2016

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov